Neuronetics R&D Spending Growth & History (STIM)
Neuronetics's r&d spending was $6.6M for fiscal 2025.
View full Neuronetics company overviewNeuronetics annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $6.6M | −$6.2M | −48.45% |
| 2024 | 2024-12-31 | $12.8M | $3.3M | +34.22% |
| 2023 | 2023-12-31 | $9.5M | $179,000 | +1.92% |
| 2022 | 2022-12-31 | $9.3M | $1.4M | +17.83% |
| 2021 | 2021-12-31 | $7.9M | −$1.3M | −13.89% |
| 2020 | 2020-12-31 | $9.2M | −$4.5M | −33.07% |
| 2019 | 2019-12-31 | $13.7M | $5.5M | +66.99% |
| 2018 | 2018-12-31 | $8.2M | $295,000 | +3.72% |
| 2017 | 2017-12-31 | $7.9M | −$286,000 | −3.48% |
| 2016 | 2016-12-31 | $8.2M | — | — |
Neuronetics quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.3M | −$462,000 | −25.70% |
| Q1 2026 | 2026-03-31 | $1.4M | −$252,000 | −15.59% |
| Q4 2025 | 2025-12-31 | $1.7M | −$4.1M | −71.13% |
| Q3 2025 | 2025-09-30 | $1.5M | −$912,000 | −37.75% |
| Q2 2025 | 2025-06-30 | $1.8M | −$437,000 | −19.55% |
| Q1 2025 | 2025-03-31 | $1.6M | −$733,000 | −31.20% |
| Q4 2024 | 2024-12-31 | $5.8M | $3.6M | +161.60% |
| Q3 2024 | 2024-09-30 | $2.4M | $261,000 | +12.11% |
| Q2 2024 | 2024-06-30 | $2.2M | −$129,000 | −5.46% |
| Q1 2024 | 2024-03-31 | $2.3M | −$441,000 | −15.81% |
| Q4 2023 | 2023-12-31 | $2.2M | −$934,000 | −29.75% |
| Q3 2023 | 2023-09-30 | $2.2M | −$193,000 | −8.22% |
| Q2 2023 | 2023-06-30 | $2.4M | $319,000 | +15.60% |
| Q1 2023 | 2023-03-31 | $2.8M | $987,000 | +54.74% |
| Q4 2022 | 2022-12-31 | $3.1M | $1.4M | +80.15% |
| Q3 2022 | 2022-09-30 | $2.3M | $773,000 | +49.08% |
| Q2 2022 | 2022-06-30 | $2.0M | −$249,000 | −10.85% |
| Q1 2022 | 2022-03-31 | $1.8M | −$508,000 | −21.98% |
| Q4 2021 | 2021-12-31 | $1.7M | −$369,000 | −17.47% |
| Q3 2021 | 2021-09-30 | $1.6M | −$377,000 | −19.31% |
| Q2 2021 | 2021-06-30 | $2.3M | $178,000 | +8.41% |
| Q1 2021 | 2021-03-31 | $2.3M | −$710,000 | −23.50% |
| Q4 2020 | 2020-12-31 | $2.1M | −$2.1M | −50.28% |
| Q3 2020 | 2020-09-30 | $2.0M | −$1.5M | −44.05% |
| Q2 2020 | 2020-06-30 | $2.1M | −$1.1M | −34.37% |
| Q1 2020 | 2020-03-31 | $3.0M | $235,000 | +8.44% |
| Q4 2019 | 2019-12-31 | $4.2M | $2.0M | +91.18% |
| Q3 2019 | 2019-09-30 | $3.5M | $1.4M | +64.19% |
| Q2 2019 | 2019-06-30 | $3.2M | $894,000 | +38.37% |
| Q1 2019 | 2019-03-31 | $2.8M | $1.2M | +79.16% |
| Q4 2018 | 2018-12-31 | $2.2M | $303,000 | +15.79% |
| Q3 2018 | 2018-09-30 | $2.1M | $282,000 | +15.30% |
| Q2 2018 | 2018-06-30 | $2.3M | $183,000 | +8.52% |
| Q1 2018 | 2018-03-31 | $1.6M | −$473,000 | −23.32% |
| Q4 2017 | 2017-12-31 | $1.9M | — | — |
| Q3 2017 | 2017-09-30 | $1.8M | — | — |
| Q2 2017 | 2017-06-30 | $2.1M | — | — |
| Q1 2017 | 2017-03-31 | $2.0M | — | — |
Neuronetics r&d spending trends
Over the last five fiscal years, Neuronetics's r&d spending decreased from $9.2M to $6.6M, a change of −$2.6M. The latest reported quarter, Q2 2026, shows $1.3M.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Neuronetics source filings ↗